A Comparison of Seegene Technologies Novaplex SARS-CoV-2 Variants I, II, and IV Assays with Spike Gene Sequencing for Detection of Known Severe Acute Respiratory Syndrome Coronavirus 2 Variants
- PMID: 35218945
- PMCID: PMC8865930
- DOI: 10.1016/j.jmoldx.2022.02.001
A Comparison of Seegene Technologies Novaplex SARS-CoV-2 Variants I, II, and IV Assays with Spike Gene Sequencing for Detection of Known Severe Acute Respiratory Syndrome Coronavirus 2 Variants
Abstract
Tracking new and emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants has become increasingly important for public health responses, primarily because of variant-dependent transmission, disease severity, and treatment decisions. This evaluation compared Seegene Technologies Novaplex SARS-CoV-2 Variants I, II, and IV (I,II&IV) assays to detect known SARS-CoV-2 variants using traditional spike gene Sanger sequencing results as the gold standard reference. Both RNA extraction and extraction-free protocols were assessed. A total of 156 samples were included in this study. There was 100% (109/109) overall agreement (95% CI, 96.7%-100%) between the spike gene sequencing and the I,II&IV results using extracted RNA for the variants included in the Novaplex assay menus. The RNA extraction-free method was 91.7% (143/156) as sensitive (95% CI, 86.2%-95.5%) as the traditional RNA extraction method. Using the extraction-free method on samples with higher cycle threshold values (>30) resulted in some mutations not being detected, presumably due to lower nucleic acid concentrations in the original samples. In conclusion, the I,II&IV assays provide an accurate, rapid, and less labor-intensive method for detecting SARS-CoV-2 and identifying known variants of interest and concern. The RNA extraction-free method for samples with cycle threshold of <30 could be cost-effective for surveillance purposes. However, spike gene sequencing retains the advantage of detecting more and new variants.
Copyright © 2022 Association for Molecular Pathology and American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.
Figures

Similar articles
-
Two-Period Study Results from a Large Italian Hospital Laboratory Attesting SARS-CoV-2 Variant PCR Assay Evolution.Microbiol Spectr. 2022 Dec 21;10(6):e0292222. doi: 10.1128/spectrum.02922-22. Epub 2022 Nov 21. Microbiol Spectr. 2022. PMID: 36409091 Free PMC article.
-
Precision Response to the Rise of the SARS-CoV-2 B.1.1.7 Variant of Concern by Combining Novel PCR Assays and Genome Sequencing for Rapid Variant Detection and Surveillance.Microbiol Spectr. 2021 Sep 3;9(1):e0031521. doi: 10.1128/Spectrum.00315-21. Epub 2021 Aug 11. Microbiol Spectr. 2021. PMID: 34378966 Free PMC article.
-
Real-Time RT-PCR Allelic Discrimination Assay for Detection of N501Y Mutation in the Spike Protein of SARS-CoV-2 Associated with B.1.1.7 Variant of Concern.Microbiol Spectr. 2022 Feb 23;10(1):e0068121. doi: 10.1128/spectrum.00681-21. Epub 2022 Feb 16. Microbiol Spectr. 2022. PMID: 35170989 Free PMC article.
-
Molecular biology of SARS-CoV-2 and techniques of diagnosis and surveillance.Adv Clin Chem. 2024;118:35-85. doi: 10.1016/bs.acc.2023.11.003. Epub 2023 Dec 14. Adv Clin Chem. 2024. PMID: 38280807 Review.
-
Structural impact of a new spike Y170W mutation detected in early emerging SARS-CoV-2 Omicron variants in France.Virus Res. 2024 May;343:199354. doi: 10.1016/j.virusres.2024.199354. Epub 2024 Mar 16. Virus Res. 2024. PMID: 38492859 Free PMC article. Review.
Cited by
-
Vaccination Decreases the Infectious Viral Load of Delta Variant SARS-CoV-2 in Asymptomatic Patients.Viruses. 2022 Sep 18;14(9):2071. doi: 10.3390/v14092071. Viruses. 2022. PMID: 36146877 Free PMC article.
-
Simultaneous detection of omicron and other SARS-CoV-2 variants by multiplex PCR MassARRAY technology.Sci Rep. 2023 Feb 6;13(1):2089. doi: 10.1038/s41598-023-28715-9. Sci Rep. 2023. PMID: 36747014 Free PMC article.
-
Evaluation of a commercial SARS-CoV-2 multiplex PCR genotyping assay for variant identification in resource-scarce settings.PLoS One. 2022 Jun 24;17(6):e0269071. doi: 10.1371/journal.pone.0269071. eCollection 2022. PLoS One. 2022. PMID: 35749403 Free PMC article.
-
Molecular Epidemiology of SARS-CoV-2 within Accra Metropolis Postlockdown.Adv Virol. 2024 Mar 29;2024:2993144. doi: 10.1155/2024/2993144. eCollection 2024. Adv Virol. 2024. PMID: 38584794 Free PMC article.
-
SARS-CoV-2 Variants Identification: Overview of Molecular Existing Methods.Pathogens. 2022 Sep 17;11(9):1058. doi: 10.3390/pathogens11091058. Pathogens. 2022. PMID: 36145490 Free PMC article. Review.
References
-
- Campbell F., Archer B., Laurenson-Schafer H., Jinnai Y., Konings F., Batra N., Pavlin B., Vandemaele K., Van Kerkhove M.D., Jombart T., Morgan O., le Polain de Waroux O. Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021. Eurosurveillance. 2021;26:2100509. - PMC - PubMed
-
- Davies N., Abbott S., Barnard R., Jarvis C., Kucharski A., Munday J., Pearson C., Russell T., Tully D., Washburne A., Wenseleers T., Gimma A., Waites W., Wong K., van Zandvoort K., Silverman J., Diaz-Ordaz K., Keogh R., Eggo R., Funk S., Jit M., Atkins K., Edmunds W. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science. 2021;372:eabg3055. - PMC - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous